Skip to main content
Erschienen in: European Journal of Pediatrics 4/2009

01.04.2009 | Original Paper

Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey—1945 to 2005

verfasst von: Irja Lutsar, Ioana Anca, Mustafa Bakir, Vytautas Usonis, Roman Prymula, Nuran Salman, Pawel Grezesiowski, Michael Greenberg, on behalf of the Central European Vaccination Advisory Group (CEVAG)

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Pertussis epidemiology was examined in selected Central and Eastern European countries andTurkey (CEEs) from 1945 to 2005. Epidemiology and immunisation coverage data were collected fromNational Health Departments and Epidemiology Institutes. Pertussis diagnosis was made by the World Health Organization (WHO) clinical criteria, laboratory confirmation and/or epidemiological link, except for Romania (WHO clinical case definition used). In the pre-vaccine era, pertussis incidence (except Turkey) exceeded 200/100,000 (range180–651/100,000), with 60-70% of cases occurring in pre-school children. Until 2007, a second-year booster was givenin Estonia, Lithuania and Turkey, and an additional pre-school booster elsewhere. During 1995–2005, immunisation coverage by the age of 2 years exceeded 80% (range 80–98%) and, excluding Estonia, pertussis incidence was <3/100,000. Age-specific incidence rates rose in 5–14 year olds in Poland, Estonia and the Czech Republic. Incidence rates in children <1 year of age remained unchanged. There were two age distribution patterns. In the Czech Republic and Estonia, 16% of cases occurred in pre-school children and 17% and 22% in children >15 years of age, respectively; in Romania, Turkey and Lithuania, 51%, 71% and 73%, respectively, occurred in pre-school children and <7% in children aged >15 years.Pertussis infection persists, despite high immunisation coverage. Compared with the pre-vaccine era, the age distribution changed differentially in CEEs, with an apparent shift towards older children.
Literatur
1.
Zurück zum Zitat Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group (2005) Resurgence of pertussis in Europe. Pediatr Infect Dis J 24:761–765PubMedCrossRef Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group (2005) Resurgence of pertussis in Europe. Pediatr Infect Dis J 24:761–765PubMedCrossRef
2.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2002) Pertussis—United States, 1997–2000. MMWR Morb Mortal Wkly Rep 51:73–76 Centers for Disease Control and Prevention (CDC) (2002) Pertussis—United States, 1997–2000. MMWR Morb Mortal Wkly Rep 51:73–76
4.
Zurück zum Zitat Dilli D, Bostanci I, Dallar Y, Buzgan T, Irmak H, Torunoğlu MA (2008) Recent findings on pertussis epidemiology in Turkey. Eur J Clin Microbiol Infect Dis 27:335–341PubMedCrossRef Dilli D, Bostanci I, Dallar Y, Buzgan T, Irmak H, Torunoğlu MA (2008) Recent findings on pertussis epidemiology in Turkey. Eur J Clin Microbiol Infect Dis 27:335–341PubMedCrossRef
5.
Zurück zum Zitat Edwards KM (2005) Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 24(6 Suppl):S104–S108PubMed Edwards KM (2005) Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 24(6 Suppl):S104–S108PubMed
6.
Zurück zum Zitat Gustafsson L, Hessel L, Storsaeter J, Olin P (2006) Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 118(3):978–984PubMedCrossRef Gustafsson L, Hessel L, Storsaeter J, Olin P (2006) Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 118(3):978–984PubMedCrossRef
7.
Zurück zum Zitat Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J (2004) Pertussis in Poland. Int J Epidemiol 33:358–365PubMedCrossRef Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J (2004) Pertussis in Poland. Int J Epidemiol 33:358–365PubMedCrossRef
9.
Zurück zum Zitat Hewlett EL, Edwards KM (2005) Clinical practice. Pertussis—not just for kids. N Engl J Med 352:1215–1222PubMedCrossRef Hewlett EL, Edwards KM (2005) Clinical practice. Pertussis—not just for kids. N Engl J Med 352:1215–1222PubMedCrossRef
10.
Zurück zum Zitat Inandi T, Guraksin A, Hacialioglu N (2005) Seroprevalence of pertussis among children in Eastern Turkey. Public Health 119:550–555PubMedCrossRef Inandi T, Guraksin A, Hacialioglu N (2005) Seroprevalence of pertussis among children in Eastern Turkey. Public Health 119:550–555PubMedCrossRef
11.
Zurück zum Zitat Jogiste A, Varjas J, Jarviste A (2005) Pertussis in Estonia. Estonian Doctor 84:31–35 Jogiste A, Varjas J, Jarviste A (2005) Pertussis in Estonia. Estonian Doctor 84:31–35
12.
Zurück zum Zitat Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326–382PubMedCrossRef Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326–382PubMedCrossRef
13.
Zurück zum Zitat Narkeviciute I, Kavaliunaite E, Bernatoniene G, Eidukevicius R (2005) Clinical presentation of pertussis in fully immunized children in Lithuania. BMC Infect Dis 5:40PubMedCrossRef Narkeviciute I, Kavaliunaite E, Bernatoniene G, Eidukevicius R (2005) Clinical presentation of pertussis in fully immunized children in Lithuania. BMC Infect Dis 5:40PubMedCrossRef
14.
Zurück zum Zitat Tan T, Trindade E, Skowronski D (2005) Epidemiology of pertussis. Pediatr Infect Dis J 24:S10–S18PubMedCrossRef Tan T, Trindade E, Skowronski D (2005) Epidemiology of pertussis. Pediatr Infect Dis J 24:S10–S18PubMedCrossRef
15.
Zurück zum Zitat Torm S, Meriste S, Tamm E, Alusalu S, Järviste A, Lang K (2005) Pertussis outbreak in a basic school in Estonia: description, contributing factors and vaccine effectiveness. Scand J Infect Dis 37:664–668PubMedCrossRef Torm S, Meriste S, Tamm E, Alusalu S, Järviste A, Lang K (2005) Pertussis outbreak in a basic school in Estonia: description, contributing factors and vaccine effectiveness. Scand J Infect Dis 37:664–668PubMedCrossRef
16.
Zurück zum Zitat Tozzi AE, Pandolfi E, Celentano LP, Massari M, Salmaso S, Ciofi degli Atti ML; EUVAC-NET Study Group (2007) Comparison of pertussis surveillance systems in Europe. Vaccine 25:291–297PubMedCrossRef Tozzi AE, Pandolfi E, Celentano LP, Massari M, Salmaso S, Ciofi degli Atti ML; EUVAC-NET Study Group (2007) Comparison of pertussis surveillance systems in Europe. Vaccine 25:291–297PubMedCrossRef
17.
Zurück zum Zitat Vatansever U, Cöplü N, Oner N, Sönmez C, Karasalihoglu S, Kurtoglu D, Esen B, Ekuklu G (2005) Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Med Wkly 135:531–536PubMed Vatansever U, Cöplü N, Oner N, Sönmez C, Karasalihoglu S, Kurtoglu D, Esen B, Ekuklu G (2005) Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Med Wkly 135:531–536PubMed
18.
Zurück zum Zitat Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R; APERT Study Group (2006) Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis 43:151–157PubMedCrossRef Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R; APERT Study Group (2006) Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis 43:151–157PubMedCrossRef
19.
Zurück zum Zitat Wirsing von König C-H, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J (2005) Pertussis immunization in the Global Pertussis Initiative European Region: recommended strategies and implementation considerations. Pediatr Infect Dis J 24:S87–S92PubMedCrossRef Wirsing von König C-H, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J (2005) Pertussis immunization in the Global Pertussis Initiative European Region: recommended strategies and implementation considerations. Pediatr Infect Dis J 24:S87–S92PubMedCrossRef
Metadaten
Titel
Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey—1945 to 2005
verfasst von
Irja Lutsar
Ioana Anca
Mustafa Bakir
Vytautas Usonis
Roman Prymula
Nuran Salman
Pawel Grezesiowski
Michael Greenberg
on behalf of the Central European Vaccination Advisory Group (CEVAG)
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2009
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-008-0754-6

Weitere Artikel der Ausgabe 4/2009

European Journal of Pediatrics 4/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.